We recently characterized rimocidin B (3b) and CE-108B (4b) as two polyene amides with improved pharmacological properties, produced by genetically modified Streptomyces diastaticus var. 108. Genetic and biochemical analysis of the producer strain showed, that the two amides are derived from the parental polyenes rimocidin (3a) and CE-108 (4a) by a post-PKS modification of the free side-chain carboxylic acid. This modification is mediated by an amidotransferase activity operating after the biosynthesis of rimocidin (3a) and CE-108 (4a) are completed. Two new polyenes, intermediates of the biosynthetic pathway of rimocidin (3a) and CE-108 (4a), were also isolated and shown to have some improved pharmacological properties compared with the final products.
Introduction
Polyenes are a large group of polyketides with antifungal activities, including antibiotics such as amphotericin B (1), nystatin A1, pimaricin (2a), rimocidin (3a) and candicidin, all biosynthesized by multifunctional proteins known as Type I modular polyketide synthases (Type I PKS). The biological activity of these compounds, and thus their pharmacological properties, rely on the selectivity of their binding to membrane-associated substituted sterols such * Corresponding author: fmalpart@cnb.uam.es as ergosterol or episterol (found in fungal cytoplasmic membrane or in some parasitic protozoa) (1) (2) (3) (4) . As a result of these interactions, a multi-molecular polyene/sterol complex is formed, leading to impairment of plasma membrane functions and so cell death. Although the affinity of the polyene macrolides for cholesterol-containing membranes is low, it is not low enough to avoid toxic side effects of some of these drugs. In spite of these, limitations, amphotericin B (1) is still the preferred clinical drug for treating systemic fungal infections. In order to gain insight into the structure/activity relationship, many semi-synthetic derivatives of amphotericin B (1) were generated in the last decade (5) (6) (7) (8) (9) (10) (11) (12) . Both the amino group of the sugar moiety and the side chain carboxyl group were targeted and their influence on the biological properties of this compound is starting to be understood. Most of the semi-synthetic compounds were generated by molecular modeling of amphotericin B (1), aiming to increase the selective toxicity for ergosterol-containing membranes. Thus, amphotericin B (1), an efficient old antifungal drug, became a standard for the successful generation of new drugs with increased specificity for their targets while retaining pharmacokinetic properties at least equivalent to those of the parent molecule. These findings make the macrolide polyenes an attractive model in attempts to increase the supply of lead compounds to fight serious fungal diseases. Recently, we isolated Streptomyces diastaticus var. 108 as a producer of two polyene macrolides rimocidin (3a) and CE-108 (4a) (13). A genetically modified derivative of this strain was shown to produce two new polyene macrolides: rimocidin B (3b) and CE-108B (4b). In both compounds, the free carboxyl group is substituted by an amide. The pharmacological properties of the new derivatives were significantly improved compared with those of the parent molecules, resulting in new polyene amides with higher specificity as antifungal drugs (14) . Because of the importance of the novel compounds as putative new leads, the biosynthetic steps leading to this substitution were investigated more in detail. At least two possible mechanisms were suggested: (a) an amidotransferase acting as a tailoring activity after the complete macrolactone rings were generated and (b) a non-decarboxylating Claisen condensation of malonamide during the growth of the polyketide chain. It is noteworthy that the producer strain can also synthesize oxytetracycline (13), and so malonamyl-CoA must be available as the starter unit for biosynthesis of this aromatic polyketide (15). Insights into the biosynthetic mechanism, described here, will be extremely useful in designing a strategy for genetic engineering of S. diastaticus var. 108 and perhaps other polyene producers in attempts to obtain new pharmaceuticals.
Results
Elucidation of the biosynthetic mechanism for the polyene amides. To discriminate between the two possible mechanisms for polyene amide formation, a genetic approach was taken. Whatever the mechanism, the role of the cytochrome P450 monooxygenase RimG, claimed to be responsible for oxidation of the side chain methyl group generated after condensation of methylmalonyl-CoA units by module 7 (14) , must be crucial. If an amidotransferase activity is needed for amide formation, it must presumably operate after the side chain methyl group is converted into the carboxyl group by the rimG product; on the other hand, if the amide group is incorporated by condensation of malonamylCoA during chain assembly, the rimG gene would not be needed for amide group formation. The presence or absence of polyene amides in the fermentation broth of a rimG disruptant when a plasmid involved in the polyene amide biosynthesis is cloned into it should indicate the correct mechanism. We therefore attempted disruption of the rimG gene by insertional inactivation. rimocidin; 3b: rimocidin B; 3c: rimocidin C; 4a: CE-108; 4b: CE-108B; 4c: CE-108C. Table 1 ). Right: deduced chemical structures for the corresponding aglycones: CE-108 aglycone (1), CE-108C aglycone (2), rimocidin aglycone (3), and rimocidin C aglycone (4). It is noteworthy that the absence of polyene amides in the fermentation broth of this recombinant strain, in which the glycosyltransferase RimE is not present, strongly suggests that the native polyenes (CE-108 and rimocidin), but not their aglycones, are the substrates for the amidotransferase activity. Because rimG lies within a long polycistronic transcript of 9 kbp, which also contains rimE, rimF, rimG, rimH and rimA (16) (Figure 2A ), it was necessary to prevent polar effects on genes located downstream of the insertion point. The ermE P promoter, in the correct orientation to drive transcription of the messenger RNA, was therefore ligated into the 0.6-kbp SacII fragment internal to the coding region of rimG (coordinates 8267-8849 bp of the sequence deposited under accession number AY422255). The resulting construct was cloned in the PM1 phage vector in several steps described in Table 1 ; the resulting recombinant phage, PM1-768B, carrying the desired construct was used to infect S. diastaticus var. 108, giving rise to lysogens S. diastaticus var. 108::PM1-768. Correct insertion into the chromosome was confirmed by Southern blotting. No tetraenes were detected in the fermentation broth when several lysogens were analyzed by HPLC, suggesting that low expression of the ermE P promoter was responsible for the non-producer phenotype. Unfortunately, further attempts to disrupt rimG using a stronger promoter (ermE P *) were unsuccessful. Two genes downstream of the insertion point could be influenced by the polar effect: rimH (coding for a ferredoxin, presumably participating in the same oxidative step as rimG) and rimA (coding for the PKS component carrying the loading domain of rimocidin (3a) and CE-108 (4a) (Figure 2A ). Because the rimH product acts in concert with that of rimG, it is reasonable that proper rimA expression would be the critical parameter for restoring formation of the polyene macrolides. In order to overcome this putative polar effect and assure proper expression of the rimA gene, the pSM743B plasmid (carrying an engineered rimA) was used. This plasmid was previously shown to be functional for both complementation of rimA disruption and induction of polyene amide formation (14) . pSM743B was therefore transferred by intraspecific conjugation from the wild type (S. diastaticus var. 108/743B) to the rimG disruptant, giving S. diastaticus var. 108::PM1-768/743B. Correct integration of PM1-768B in the genome of S. diastaticus var. 108 and the presence of the plasmid pSM743B were confirmed by Southern blotting. When the fermentation broth of S. diastaticus var. 108::PM1-768/743B was analyzed by HPLC, two major compounds with the same spectrum and retention time as those of rimocidin (3a) and CE-108 (4b) were detected: peaks 1 and 2 ( Figure 2B ). HPLC-MS analysis showed that the deduced masses of peaks 1 and 2 were 709 and 737, 30 units lower than for rimocidin (3a) and CE-108 (4a). The mass differences are consistent with the expected structures of the compounds generated by rimG disruption: a methyl group at C-14 instead of the carboxyl group of rimocidin (3a) and CE-108 (4a). The two new tetraenes were named CE-108C (4c) and rimocidin C (3c) for the lower and higher retention time respectively and their deduced chemical structures are shown in Figure 2C .
No polyene amides were detected in the fermentation broth of the rimG disruptants, suggesting that amide group formation takes place through a tailoring amidotransferase activity on the free carboxyl group rather than during assembly of the polyketide chain. Thus, the substrates for the tailoring amidotransferase reaction would contain the complete CE-108 (4a) and rimocidin (3a) aglycones.
rimE Gene Disruption It remained unclear whether the substrates of the tailoring activity were CE-108 (4a) and rimocidin (3a) or their corresponding aglycones before glycosylation at C-17 with the mycosamine moiety. In order to distinguish between these two possibilities, a new disruptant of rimE (encoding the glycosyltransferase (16)) was made. To prevent possible polar effects on downstream genes, the fragment for disruption was engineered with ermE P *, a stronger promoter than that previously used (16) . The 0.8-kbp SalI fragment internal to the coding region of rimE (coordinates 5629-6484 bp of the sequence AY442225) was first cloned into the pEL1 plasmid (Table 1) downstream of the ermE P * promoter; and the ermEp* promoter and the 0.8-kb SalI fragment were rescued and cloned in the PM1 vector. The resulting recombinant phage (PM1-702B) (see Table 1 ) was used to generate lysogens S. diastaticus var. 108/PM1-702B; the expected insertion was confirmed by Southern blotting. Fermentation broths from the lysogens were analyzed by HPLC and all of them showed the presence of four major peaks (A-D) with spectra corresponding to typical tetraenes. HPLC-MS analysis confirmed their masses. While peaks A and C showed the expected masses for the CE-108 (4a) and rimocidin (3a) aglycones respectively, the masses for peaks B and D were consistent with the aglycones of CE-108 (4a) and rimocidin (3a) carrying a methyl side chain instead of the carboxyl group (see Figure 3) . These results were similar to those described in other glycosyltransferase disruptions (17) . No antifungal activity was detected for any of these aglycones, as previously described. These results strongly support the idea that the low production of these compounds in the former disruption was due to low expression of the promoter used rather than to their chemical instability as previously suggested (16) . Plasmid pSM743B (conferring the ability to produce the polyene amides when introduced into the wild type strain (14)) was transferred by intra-specific conjugation into the rimE disruptant S. diastaticus var. 108/PM1-702B. The desired recombinant was selected using the resistance markers and confirmed by Southern blotting and plasmid extraction. The fermentation broth of the resultant strain (S. In Vitro CE-108 and Rimocidin Amidation Asssays From the results described above, the polyene amides seem to be synthesized by a tailoring activity whose substrates would be the native tetraenes CE-108 (4a) and rimocidin (3a). In order to test for such activity in the fermentation broth of the polyene amide producer, S. diastaticus var. 108/784 [wild type strain carrying the plasmid which confers the ability to produce the polyene amides (14) ] was grown in SYM2 medium for three days. After testing by HPLC for production of the polyene amides, cell-free extracts were prepared as indicated in Experimental Procedures. To prevent interference with the reaction products, most of the remaining polyenes still present in this preparation were removed by solid phase extraction using a Sep-Pak C18 cartridge (Waters). A set of preliminary reactions were assayed for polyene amide production in which several parameters were tested: substrates, cofactors, amide donors and optimal pH (optimal amidotransferase activity was performed as described in Experimental Procedures); the reaction products were analyzed by HPLC. For a cleaner enzyme preparation, the pellets from several ammonium sulfate saturations (25%, 45% and 60%) were assayed for activity and shown to be associated with the 60% pellet. A clear conversion of both CE-108 (4a) and rimocidin (3a) was detected ( Figure 4A and B) . The identity of these peaks was confirmed by HPLC-MS analysis. No polyene amides were detected if ATP was absent from the enzyme reaction, suggesting that the amidotransferase activity is indeed an ATP-dependent reaction.
In Vitro Heterologous Amidation Asssay
To deduce the specificity of the polyene amidotranferase activity, pimaricin (2a) and amphotericin B (1) were used as substrates in the amidotransferase reaction along with CE-108 (4a) and rimocidin (3a) as control. The cellfree extracts and the reactions were performed as described in Experimental Procedures. As shown in Figure 4C , a protein extract from S. diastaticus var. 108/784 could also convert pimaricin (2a) into its corresponding amide AB-400 (2b) (18) . No conversion of amphotericin B (1) was detected, suggesting that the amidotransferase from S. diastaticus var. 108 does not recognize 1 as substrate under our experimental conditions. Cell-free extracts from Streptomyces RGU5.3 [recently characterized in our laboratory as producer of AB-400 (14)] was also tested for its amidotransferase activity. In this strain, only pimaricin (2a), but not rimocidin (3a), CE-108 (4a) nor amphotericin B (1), could be converted into their corresponding amides under our experimental conditions, suggesting that this activity is more specific in substrate recognition than that of S. diastaticus var. 108 (see Figure 5 ).
Characterization of Rimocidin C and CE-108C Chemical Structure Elucidation
In order to verify the chemical structures of the new tetraenes CE-108C (4c) and rimocidin C (3c), they were purified from the fermentation broth of S. diastaticus var. 14 ) , this corresponds to the loss of two oxygen atoms and the addition of two protons in 3c, which can formally be interpreted as an exchange of the carboxy group at C-14 against a methyl residue. The 1 H NMR spectrum was very similar to that of rimocidin (3a) and displayed three signals in the sp 2 range, i.e. a doublet of doublet (dd) at δ 6.30, a multiplet at δ 6.05-6.18, and a second dd at δ 5.90 ( Table 2 ). The protons of the sugar moiety appeared in the range of δ 3.25-4.62.
The aliphatic region of the 1 H NMR spectrum exhibited also similarities with that of 3a, especially with respect to five complex multiplet patterns in the range of δ 1.30-2.50. Four methyl groups instead of three as in 3a appeared as two triplets and two doublets at δ 0.90, 0.95, and 1.26, 1.00, respectively. The major difference between 3a and 3c was the presence of the methyl doublet at δ 1.00, which showed an H,H cross signal in the COSY spectrum with the 14-H at δ 1.22 (δ C 43.8).
The 13 C NMR spectrum indicated 39 carbon signals as in 3a and as demanded by the molecular formula. This and the similarity of the proton spectra permitted the conclusion that 3a and 3c possess the same carbon skeleton including the amino sugar, the only difference being the presence of only two carbonyl groups instead of three as in 3a. The signals at δ 211.6 and 174.5 were attributed to a ketone and a lactone carbonyl, respectively. The HMBC 3 J coupling of the proton at δ 5.03 (C-27) to the carbonyl at 174.5 confirmed the lactone, so that rimocidin C must be 14-decarboxy-14-methyl-rimocidin A (3c). The yellow powdery 4c was readily soluble in methanol. Here too, the 1 H NMR spectrum exhibited similarities with those of 3c and 4a (Table 3; (Table 3) indicated clearly that also in this tetraene, the C-14 carboxy group of 4a was replaced by a methyl group, which identified CE-108C as the 14-decarboxy-methyl derivate 4a.
Biological Activities of Rimocidin C and CE-108C
Antifungal activity of the new noncarboxylated tetraenes rimocidin C (3c) and CE-108C (4c) was tested against Penicillium chrysogenum and compared with that of the native tetraenes. The antifungal activities of the two intermediate tetraenes, rimocidin C (3c) and CE-108C (4c), were not significantly different from those of their final products (data not shown). To test whether or not other pharmacological properties of the new tetraenes were different, haemolytic activity assays were also performed and compared with the parental compounds. Human erythrocytes were used for these assays; the results are shown in Table 4 . It is noteworthy that although the antifungal activities of 3a and 3c were similar, their toxicity (measured in term of haemolytic activity) was 2.5-5-fold lower for rimocidin C (3c) than the parental rimocidin (3a). Up to 600 nanomols of CE-108C (4c) were used for the haemolytic assays; the detected haemolysis was less than 20% (data not shown), suggesting a much lower toxicity of the non-carboxylated CE-108 (4a) than for any of the other co-produced metabolites. This suggests an interesting improvement in biological properties. 
Discussion
The polyene macrolides are a large group of compounds with interesting pharmacological properties, including potent antifungal activity, broad antifungal spectrum, low probability of inducing resistance in the target strains and mechanism of action. These positive properties need to be set against negative ones such as high toxicity to mammals and very low water solubility. Because of the properties of some of these compounds, many approaches have been taken to generate new drugs: semi-synthetic derivatives with more specific antifungal effects and higher water solubility (1;6;7;10;19), and genetic manipulation of biosynthetic genes (17;20-22) . These two approaches face similar challenges: to increase the repertoire of these interesting compounds and improve the pharmacological properties of pre-existing compounds as antifungal leads. A combination of both strategies is a promising tool for generating new pharmaceuticals. Recently, we described two new polyene compounds rimocidin B (3b) and CE-108B (4b) produced by genetically modified Streptomyces diastaticus var. 108 (14) . Here we show that the new polyenes are derived from the parental compounds, rimocidin (3a) and CE-108 (4a), through modification by a tailoring ATP-dependent amidotransferase activity that converts the free carboxyl group into an amide group. Both polyenes, but not their aglycones, are substrates for such bioconversion. Under our experimental conditions, the enzyme system can also recognize the closely related polyene pimaricin (2a), but not amphotericin B (23), we previously proposed that rimG would encode a cytochrome P450 monooxygenase involved in the conversion of the side chain methyl group of the macrolactone ring of 3a and CE-108 (4a) into the free carboxylic acid (16) . Our experimental results confirm this prediction and that the products accumulated by the rimG disruptants are rimocidin C (3c) and CE-108C (4c, the corresponding methylated polyene precursors), because the C-14 methyl is not oxidized to the carboxyl group. The tetraene production profile observed in the rimG disruptant suggests that the carboxyl group is not required for attachment of mycosamine to the aglycone moiety and that the methylated CE-108 (4a) and rimocidin (3a) aglycones can also be substrates for transglycosylation. From the results of rimE and rimG disruption we cannot establish the relative order in which those tailoring gene products (RimG and RimE) operate; a feedback inhibition of post-PKS tailoring steps as suggested by Chen et al (17) cannot be excluded.
Despite the fact that the carboxyl group is highly conserved amongst polyenes, we provide evidence that this group is not needed for their biological activity; moreover, its absence led to polyenes with improved pharmacological properties compared with their oxidized counterparts. It is noteworthy that attempts to disrupt the corresponding monooxygenase gene in other polyene producers failed (24;25); there was no clear explanation. As far as we know, this is the first report describing the isolation and characterization of methylated polyenes, opening the exciting possibility that these intermediates may not be toxic for other producers as had been suggested (25 
Experimental Procedures
Bacterial Strains, Cloning Vectors and Growth Conditions. The bacterial strains and plasmids are described in Table 1 . Streptomyces diastaticus var. 108 and its derivatives were cultured in SYM2 medium (26) . Streptomyces lividans TK21 (27) was used for propagation of phages and as cloning host. E. coli JM101 was grown on Luria-Bertani (LB) agar or in LB broth (28). Penicillium chrysogenum ATCC10003 was used for testing antifungal activity and was grown in MPDA medium as previously described (16) . Genetic Procedures E. coli JM101 was grown and transformed as described elsewhere (28). Streptomyces strains were manipulated as described elsewhere (27). Intraspecific conjugation was carried out as described previously (14) . DNA manipulations were performed as described by Maniatis et al. (28) .
Assay for Tetraenes Production under Analytical Conditions
The tetraene production assays were performed as previously described (16); HPLC analyses were carried out as described elsewhere (13).
HPLC-MS Assays
The mass spectra were determined in an 1100MSD HPLC connected to a quadrupole Agilent Technology Detector, using electrospray as source and a positive ionization mode. The chromatographic conditions were the same as described above.
NMR Measurements
NMR spectra were measured on a Varian Inova 600 (599.740 MHz) spectrometer. ESI mass spectra were recorded on a Finnigan LCQ with quaternary pump Rheos 4000 (Flux Instrument). HR ESI mass spectra were measured on a Bruker FTICR 4.7 T mass spectrometer.
Purification of CE-108C and Rimocidin C
Streptomyces diastaticus var. 108::PM1-768/743B was grown on solid SYM2 medium supplemented with thiostrepton (50 µg/ml) and erythromycin (25 µg/ml) for selection of chromosomal insertion and plasmid markers respectively. After six days, the whole solid medium was fragmented and processed as described previously (14) . CE-108C (4c) and rimocidin C (3c) were purified by HPLC using a semi-preparative column (Supelcosil PLC-8, 250 x 21.2 mm); the applied gradient was similar to that previously described for analytical fractionation (14) and controlled with a Waters Automated Gradient Controller. The purified compounds were pooled and subjected to an additional desalting step using Sep-Pak C18 (Waters) cartridges and finally freeze-dried twice.
Haemolytic Activity Assay
The assays were carried out on human blood erythrocytes enriched as previously described (14) .
Cell-free Extracts Preparation and In Vitro Amidation Assays
Cell-free extracts were prepared from Streptomyces diastaticus var. 108/784 and Streptomyces sp. RGU5.3. The strains were grown in 50 ml SYM2 medium for 3 days. The mycelium was collected by centrifugation at 5,000 g and 4 ºC for 10 minutes, washed with 20% glycerol and finally resuspended in 15 ml 20% glycerol. Aliquots of 500 µl were stored at -20 ºC until use. When needed, the cells were pelleted by centrifugation and resuspended in 50 mM TrisHCl pH7.5, 0.5 mM EDTA, 5% glycerol, 50 mM NaCl, 0.5 mM PMSF and 1 mM β-mercaptoethanol (TEPM buffer). The cells were disrupted by sonication and centrifuged at 4,000 g for 15 min at 4 ºC and the supernatant was again centrifuged. The polyenes contaminating the final supernatant were partially removed by passing the samples through Sep-Pak C18 (Waters) cartridges. The extracts were subjected to ammonium sulfate fractionation and raised sequentially to 45% and 60% ammonium sulfate saturation; the pellets were collected at 30,000 g and 4 ºC for 10 minutes and dissolved at four-fold concentration in TEPM buffer. The pellet obtained at 60% ammonium sulfate saturation was used for the amidotransferase assays. The amidotransferase assays were performed in 200 µl reaction containing 100 µl of protein extract obtained as described above, 4 x 10 6
Units of Optical Density. measured at 340 nm of the corresponding polyenes, 2.5 mM glutamine, 25 mM NaCl, 10 mM MgCl 2 , 4 mM ATP and 125 mM TES buffer pH7.2. The reactions were incubated at 30 ºC for 60 minutes and stopped by addition of 1 volume of methanol, clarified by centrifugation at 4,000 g and the products analyzed by HPLC.
